FLORAL
Long-term treatment with etavopivat in people with sickle cell disorder or thalassaemia Click here
REDRESS (RElated haplo-DonoR haematopoietic stEm cell transplantation for adults with Severe Sickle cell disease)
The purpose of this trial is to determine whether stem cell transplant using haplo-identical related donors is safe, effective, and cost worthy in treating people with sickle cell disorder compared […]
NIHR Rapid Service Evaluation Team (REVAL)
Evaluation of pilot hyperacute units to deliver acute sickle cell care as part of a wider programme of quality improvement (SCD)In response to recognition of avoidable deaths and failures of […]
HIBISCUS
Exploring the use of a new drug in patients with sickle cell disease. The HIBISCUS study started at the King’s College Hospital Denmark Hill campus in June 2022 with patients […]
Haematology Lived Experience and Outcomes (HALO)
HALO is a research study looking at the survival rates of people diagnosed with Sickle Cell Disorder or Beta Thalassemia, acute Lymphoblastic or acute Myeloid Leukaemia in childhood and the long-term effects of that diagnosis and treatment.